U.S. Army to distribute antiseptic to medics treating Ebola in Africa

The U.S. Army will deploy Microdermis' Provodine product in West Africa to help fight Ebola | Microdermis Corporation

The U.S. Army will distribute a new antiseptic product in West Africa to help contain the Ebola virus, the maker of the medicine said Monday.

Microdermis Corp., a privately held life sciences company, developed the antiseptic, called Provodine, which can be used to kill more than 99 percent of Ebola virus particles on the skin. The product will help protect health care workers who are treating Ebola patients.

About 335 health care workers have died while working to stop the spread of the virus in West Africa, the company said. Testing conducted by the U.S. Army Medical Research Institute for Infection Diseases concluded that Provodine killed more than 99 percent of Ebola particles within 30 seconds of contact.

Hal Hornburg, a retired U.S. Air Force general who now serves on Microdermis' board of directors, said one of the main problems with the Ebola virus is that antiseptic products have not been effective enough to help kill the virus.

Dr. Lester Martinez-Lopez, former head of the U.S. Army's Medical Research and Materiel Command (USAMRMC), who helped guide Microdermis' strategic initiative, said the fight against Ebola has been very tough and that Provodine is "a novel and critical weapon against Ebola and many other infectious diseases."

This week, the U.S. Army Medical Research Institute of Infectious Diseases will test the product to determine whether it can kill the Ebola virus for up to nine hours after application.

Organizations in this story

U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) 1425 Porter Street Frederick, MD 21702-5011

Get notified the next time we write about U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID)!